Westwood Management Corporation’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-319,410
Closed -$29.3M 78
2016
Q1
$29.3M Buy
319,410
+1,400
+0.4% +$126K 5.56% 5
2015
Q4
$32.2M Buy
318,010
+1,500
+0.5% +$156K 6.03% 5
2015
Q3
$31.1M Hold
316,510
5.84% 6
2015
Q2
$37.1M Sell
316,510
-5,000
-2% -$546K 6.31% 5
2015
Q1
$31.6M Sell
321,510
-8,100
-2% -$822K 5.25% 7
2014
Q4
$31.1M Sell
329,610
-500
-0.2% -$51.7K 5.35% 6
2014
Q3
$35.1M Sell
330,110
-7,000
-2% -$685K 6.24% 4
2014
Q2
$27.9M Sell
337,110
-8,890
-3% -$692K 4.64% 9
2014
Q1
$24.5M Buy
346,000
+8,300
+2% +$651K 4.18% 11
2013
Q4
$25.4M Sell
337,700
-2,200
-0.6% -$153K 4.25% 9
2013
Q3
$21.4M Hold
339,900
4.07% 10
2013
Q2
$17.4M Buy
+339,900
New +$17.7M 3.74% 9

Other funds holding GILD

Westwood Management Corporation's GILD Position: Q2 2016 in Review

Westwood Management Corporation sold out of Gilead Sciences (GILD) in Q2 2016, closing a stake of 319,410 shares — an estimated $29.3M sold.

Westwood Management Corporation first reported a position in GILD in Q2 2013 and held it in 12 quarters. The position peaked at $37.1M in Q2 2015. 1,597 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

  • Westwood Management Corporation reported no remaining Gilead Sciences position as of Q2 2016 after selling out during the quarter.
  • Westwood Management Corporation sold 319,410 Gilead Sciences shares in Q2 2016, an estimated $29.3M.
  • Westwood Management Corporation first reported a position in Gilead Sciences in Q2 2013 and held it in 12 quarters.
  • Westwood Management Corporation's Gilead Sciences position peaked at $37.1M in Q2 2015.
  • 1,597 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on Westwood Management Corporation's 13F filing for Q2 2016, filed 21 Jul 2016.